Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Social influences on clinical outcomes of patients with ovarian cancer.

Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Zimmerman MB, Penedo FJ, Lucci JA 3rd, Ganjei-Azar P, Thaker PH, Mendez L, Lubaroff DM, Slavich GM, Cole SW, Sood AK.

J Clin Oncol. 2012 Aug 10;30(23):2885-90. doi: 10.1200/JCO.2011.39.4411. Epub 2012 Jul 16.

2.

Prognostic impact of marital status on survival of women with epithelial ovarian cancer.

Mahdi H, Kumar S, Munkarah AR, Abdalamir M, Doherty M, Swensen R.

Psychooncology. 2013 Jan;22(1):83-8. doi: 10.1002/pon.2058. Epub 2011 Sep 15.

PMID:
21919121
3.

Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.

García-Sáenz JA, Custodio A, Casado A, Vidart JA, Coronado PJ, Martín M, López-Tarruella S, Puente J, Fernández C, Díaz-Rubio E.

Clin Transl Oncol. 2011 Feb;13(2):121-32. doi: 10.1007/s12094-011-0629-6. Review.

PMID:
21324801
4.

Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.

Davis LZ, Slavich GM, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Farley DM, Markon KE, Penedo FJ, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Cancer. 2015 Oct 1;121(19):3543-50. doi: 10.1002/cncr.29516. Epub 2015 Jun 10.

PMID:
26096769
5.

Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.

Sijmons EA, van Lankveld MA, Witteveen PO, Peeters PH, Koot VC, van Leeuwen JS.

Eur J Obstet Gynecol Reprod Biol. 2007 Apr;131(2):203-8. Epub 2006 May 16.

PMID:
16707204
6.

Surgical cytoreduction for recurrent epithelial ovarian cancer.

Al Rawahi T, Lopes AD, Bristow RE, Bryant A, Elattar A, Chattopadhyay S, Galaal K.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD008765. doi: 10.1002/14651858.CD008765.pub3. Review.

PMID:
23450588
7.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Review.

PMID:
21833960
8.

Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.

Muraji M, Sudo T, Iwasaki S, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Nishimura R.

Gynecol Oncol. 2013 Dec;131(3):531-4. doi: 10.1016/j.ygyno.2013.09.030. Epub 2013 Oct 4.

PMID:
24096109
9.
10.

Social support, psychological distress, and natural killer cell activity in ovarian cancer.

Lutgendorf SK, Sood AK, Anderson B, McGinn S, Maiseri H, Dao M, Sorosky JI, De Geest K, Ritchie J, Lubaroff DM.

J Clin Oncol. 2005 Oct 1;23(28):7105-13.

11.

Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.

Vernooij F, Heintz AP, Witteveen PO, van der Heiden-van der Loo M, Coebergh JW, van der Graaf Y.

J Natl Cancer Inst. 2008 Mar 19;100(6):399-406. doi: 10.1093/jnci/djn033. Epub 2008 Mar 11.

12.

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.

13.

The survival detriment of venous thromboembolism with epithelial ovarian cancer.

Gunderson CC, Thomas ED, Slaughter KN, Farrell R, Ding K, Farris RE, Lauer JK, Perry LJ, McMeekin DS, Moore KN.

Gynecol Oncol. 2014 Jul;134(1):73-7. doi: 10.1016/j.ygyno.2014.04.046. Epub 2014 May 1.

PMID:
24793732
14.

Green tea consumption enhances survival of epithelial ovarian cancer.

Zhang M, Lee AH, Binns CW, Xie X.

Int J Cancer. 2004 Nov 10;112(3):465-9.

15.

Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?

Lydiksen L, Jensen-Fangel S, Blaakaer J.

Gynecol Oncol. 2014 Jun;133(3):454-9. doi: 10.1016/j.ygyno.2014.04.004. Epub 2014 Apr 12.

PMID:
24726613
16.

Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs.

Butow PN, Price MA, Bell ML, Webb PM, deFazio A; Australian Ovarian Cancer Study Group; Australian Ovarian Cancer Study Quality Of Life Study Investigators, Friedlander M.

Gynecol Oncol. 2014 Mar;132(3):690-7. doi: 10.1016/j.ygyno.2014.01.002. Epub 2014 Jan 11.

PMID:
24423880
17.

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.

Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY.

Gynecol Oncol. 1999 Mar;72(3):278-87.

PMID:
10053096
18.

Vascular endothelial growth factor and social support in patients with ovarian carcinoma.

Lutgendorf SK, Johnsen EL, Cooper B, Anderson B, Sorosky JI, Buller RE, Sood AK.

Cancer. 2002 Aug 15;95(4):808-15.

19.

The impact of body weight on ovarian cancer outcomes.

Backes FJ, Nagel CI, Bussewitz E, Donner J, Hade E, Salani R.

Int J Gynecol Cancer. 2011 Dec;21(9):1601-5. doi: 10.1097/IGC.0b013e31822d2aa3.

20.

The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.

Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, Park SY.

Gynecol Oncol. 2006 Dec;103(3):977-84. Epub 2006 Jul 11.

PMID:
16837030
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk